Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair

Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair

Bibliographic Details
Main Authors:	Xin Peng, Yingying Wang, Shaolu Zhang, Zhennan Tao, Yuxiang Dai, Francois X. Claret, Moshe Elkabets, Hou-Wen Lin, Zhe-Sheng Chen, Dexin Kong
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-03-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-023-01324-8

Similar Items

Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair
by: Xin Peng, et al.
Published: (2023-01-01)

Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.
by: Gottipati, P, et al.
Published: (2010)

The Antiviral Activities of Poly-ADP-Ribose Polymerases
by: Mathilde Malgras, et al.
Published: (2021-03-01)

Poly(ADP-ribose) Polymerase-1 in the Nervous System
by: Hyo Chol Ha, et al.
Published: (2000-08-01)

Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents
by: Emad Matanes, et al.
Published: (2021-10-01)

Poly ADP-ribose polymerase-1: an international molecule of mystery.
by: Woodhouse, B, et al.
Published: (2008)

Family-wide analysis of poly(ADP-ribose) polymerase activity
by: Vyas, Sejal, et al.
Published: (2015)

The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in Gliomas
by: Nazanin Majd, et al.
Published: (2020-11-01)

Poly-ADP-ribose polymerase (PARP) inhibitors and ovarian function
by: Jiajia Li, et al.
Published: (2023-01-01)

Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
by: Maurie Markman
Published: (2018-01-01)

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy
by: M. Javle, et al.
Published: (2011-11-01)

Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
by: Chia-Hao Liu, et al.
Published: (2017-10-01)

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
by: Stephen A. Jannetti, et al.
Published: (2020-03-01)

Analysis of poly(ADP-Ribose) polymerases in Arabidopsis telomere biology.
by: Kara A Boltz, et al.
Published: (2014-01-01)

BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair
by: Shaolu Zhang, et al.
Published: (2021-05-01)

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.
by: Molnár, A, et al.
Published: (2006)

Cooperative nucleic acid binding by Poly ADP-ribose polymerase 1
by: Manana Melikishvili, et al.
Published: (2024-03-01)

Plasma and Peritoneal Poly (ADP-Ribose) Polymerase Levels in Patients with Endometriosis
by: Joanna Kacperczyk-Bartnik, et al.
Published: (2022-10-01)

Update on poly(ADP-ribose) polymerase inhibitors resistance in ovarian cancer
by: Ruihong Dong, et al.
Published: (2023-06-01)

Recognition of Platinum−DNA Damage by Poly(ADP-ribose) Polymerase-1
by: Zhu, Guangyu, et al.
Published: (2011)

Structure and function of the human Poly(ADP-ribose) polymerase enzyme family
by: Rood, Jennifer E. (Jennifer Evelyn)
Published: (2013)

The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer
by: Jeanny B Aragon-Ching
Published: (2016-01-01)

Poly(ADP-Ribose) Polymerase 1: Cellular Pluripotency, Reprogramming, and Tumorogenesis
by: Bo-Hua Jiang, et al.
Published: (2015-07-01)

Multiple facets of poly(ADP-ribose) polymerase-1 in neurological diseases
by: Chandra Shaker Sriram, et al.
Published: (2015-01-01)

Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy
by: Bijay Singh, et al.
Published: (2020-11-01)

Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity
by: Seong-Woon Yu, et al.
Published: (2003-12-01)

Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes
by: Teotia Sachin, et al.
Published: (2010-10-01)

Selection of potential natural compounds for poly-ADP-ribose polymerase (PARP) inhibition in glioblastoma therapy by in silico screening methods
by: Arunraj Tharamelveliyil Rajendran, et al.
Published: (2023-07-01)

Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
by: Daniel Harrision, et al.
Published: (2020-08-01)

Fine-tuning of Smad protein function by poly(ADP-ribose) polymerases and poly(ADP-ribose) glycohydrolase during transforming growth factor β signaling.
by: Markus Dahl, et al.
Published: (2014-01-01)

Poly (ADP-ribose) Polymerase Promoter Hypermethylation Predispose Females to Breast Cancer
by: Hussein Sabit, et al.
Published: (2019-04-01)

Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer
by: Andrisha-Jade Inderjeeth, et al.
Published: (2022-11-01)

Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
by: Haruka Hiroki, et al.
Published: (2023-05-01)

Cellular functions and enzymatic activity of the poly(ADP-ribose) polymerase protein family
by: Vyas, Sejal (Sejal Kamlesh)
Published: (2014)

Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach
by: Zaffini R, et al.
Published: (2018-02-01)

The Dichotomy of the Poly(ADP-Ribose) Polymerase-Like Thermozyme from Sulfolobus solfataricus
by: Maria Rosaria Faraone Mennella
Published: (2018-01-01)

Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer
by: Jingsong Zhang
Published: (2014-06-01)

Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes
by: Sarkar Oli, et al.
Published: (2009-12-01)

PROTEOLYTIC DEGRADATION OF POLY (ADP-RIBOSE) POLYMERASE IN RATS WITH CARRAGEENAN-INDUCED GASTROENTEROCOLITIS
by: Tkachenko A. S., et al.
Published: (2017-12-01)

Poly (ADP-ribose) polymerase 1 is required for protein localization to Cajal body.
by: Elena Kotova, et al.
Published: (2009-02-01)